Wesana Health (OTC: WSNAF) is a life sciences company focused on the advancement of psychedelic medicines that will target traumatic brain injuries. The company’s CEO Daniel Carcillo is a former professional hockey player who can speak from the experience of having suffered numerous injuries. He believes the Wesana clinics will offer better treatment than the currently trendy “ketamine mills.” He says Wesana will focus on insurance reimbursement.